{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T05:36:08Z","timestamp":1791005768311,"version":"4.1.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["820736378"],"award-info":[{"award-number":["820736378"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82122060"],"award-info":[{"award-number":["82122060"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2021M700841"],"award-info":[{"award-number":["2021M700841"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012152","name":"National Postdoctoral Program for Innovative Talents","doi-asserted-by":"publisher","award":["BX2021077"],"award-info":[{"award-number":["BX2021077"]}],"id":[{"id":"10.13039\/501100012152","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013277","name":"National Clinical Key Specialty Project Foundation","doi-asserted-by":"publisher","award":["2019FY101103"],"award-info":[{"award-number":["2019FY101103"]}],"id":[{"id":"10.13039\/501100013277","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013277","name":"National Clinical Key Specialty Project Foundation","doi-asserted-by":"publisher","award":["2019YFC1315804"],"award-info":[{"award-number":["2019YFC1315804"]}],"id":[{"id":"10.13039\/501100013277","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.metabol.2022.155270","type":"journal-article","created":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T23:24:54Z","timestamp":1659137094000},"page":"155270","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Dissecting causal relationships between nonalcoholic fatty liver disease proxied by chronically elevated alanine transaminase levels and 34 extrahepatic diseases"],"prefix":"10.1016","volume":"135","author":[{"given":"Zhenqiu","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Suo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiejun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingdong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2022.155270_bb0005","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2022.155270_bb0010","article-title":"2019 global NAFLD prevalence: a systematic review and meta-analysis","author":"Le","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.metabol.2022.155270_bb0015","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S2468-1253(21)00020-0","article-title":"Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach","volume":"6","author":"Targher","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.metabol.2022.155270_bb0020","article-title":"Complications, morbidity and mortality of nonalcoholic fatty liver disease","volume":"111s","author":"Mantovani","year":"2020","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2022.155270_bb0025","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/eurjpc\/zwab212","article-title":"Risk of cardiovascular events in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"29","author":"Alon","year":"2022","journal-title":"EurJ Prev Cardiol"},{"key":"10.1016\/j.metabol.2022.155270_bb0030","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1161\/STROKEAHA.120.030433","article-title":"Severity of nonalcoholic fatty liver disease and risk of future ischemic stroke events","volume":"52","author":"Xu","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.metabol.2022.155270_bb0035","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/jgh.14856","article-title":"Non-alcoholic fatty liver disease and the incidence of myocardial infarction: a cohort study","volume":"35","author":"Sinn","year":"2020","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.metabol.2022.155270_bb0040","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1016\/j.cgh.2019.12.026","article-title":"Nonalcoholic fatty liver disease and fibrosis associated with increased risk of cardiovascular events in a prospective study","volume":"18","author":"Baratta","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.metabol.2022.155270_bb0045","article-title":"Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults","volume":"367","author":"Alexander","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.metabol.2022.155270_bb0050","doi-asserted-by":"crossref","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","article-title":"Mendelian randomization: genetic anchors for causal inference in epidemiological studies","volume":"23","author":"Davey Smith","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.metabol.2022.155270_bb0055","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.ajhg.2022.04.001","article-title":"Combining evidence from Mendelian randomization and colocalization: review and comparison of approaches","volume":"109","author":"Zuber","year":"2022","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.metabol.2022.155270_bb0060","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jhep.2020.03.006","article-title":"Causal relationships between NAFLD, T2D and obesity have implications for disease subphenotyping","volume":"73","author":"Liu","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2022.155270_bb0065","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1111\/ene.15277","article-title":"Non-alcoholic fatty liver disease and stroke: a Mendelian randomization study","volume":"29","author":"Wu","year":"2022","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.metabol.2022.155270_bb0070","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/eurheartj\/ehx662","article-title":"Liver fat content, non-alcoholic fatty liver disease, and ischaemic heart disease: Mendelian randomization and meta-analysis of 279 013 individuals","volume":"39","author":"Lauridsen","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.metabol.2022.155270_bb0075","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/hep4.1319","article-title":"Relationship between nonalcoholic fatty liver disease susceptibility genes and coronary artery disease","volume":"3","author":"Brouwers","year":"2019","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.metabol.2022.155270_bb0080","article-title":"Electronic health record-based genome-wide meta-analysis provides insights on the genetic architecture of non-alcoholic fatty liver disease","volume":"2","author":"Ghodsian","year":"2021","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.metabol.2022.155270_bb0085","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jhep.2020.04.003","article-title":"Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort(\u2606)","volume":"73","author":"Anstee","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2022.155270_bb0090","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/s41588-022-01078-z","article-title":"A multiancestry genome-wide association study of unexplained chronic ALT elevation as a proxy for nonalcoholic fatty liver disease with histological and radiological validation","volume":"54","author":"Vujkovic","year":"2022","journal-title":"Nat Genet"},{"key":"10.1016\/j.metabol.2022.155270_bb0095","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","article-title":"Interpreting findings from Mendelian randomization using the MR-egger method","volume":"32","author":"Burgess","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.metabol.2022.155270_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ije\/dyg070","article-title":"'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease?","volume":"32","author":"Smith","year":"2003","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.metabol.2022.155270_bb0105","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/ije\/dyr036","article-title":"Avoiding bias from weak instruments in Mendelian randomization studies","volume":"40","author":"Burgess","year":"2011","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.metabol.2022.155270_bb0110","doi-asserted-by":"crossref","first-page":"5434","DOI":"10.1002\/sim.9133","article-title":"Testing and correcting for weak and pleiotropic instruments in two-sample multivariable Mendelian randomization","volume":"40","author":"Sanderson","year":"2021","journal-title":"Stat Med"},{"key":"10.1016\/j.metabol.2022.155270_bb0115","first-page":"1961","article-title":"Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-egger regression: the role of the I2 statistic","volume":"45","author":"Bowden","year":"2016","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.metabol.2022.155270_bb0120","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1177\/0962280206077743","article-title":"Mendelian randomization as an instrumental variable approach to causal inference","volume":"16","author":"Didelez","year":"2007","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.metabol.2022.155270_bb0125","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"key":"10.1016\/j.metabol.2022.155270_bb0130","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/gepi.22295","article-title":"A comparison of robust Mendelian randomization methods using summary data","volume":"44","author":"Slob","year":"2020","journal-title":"Genet Epidemiol"},{"key":"10.1016\/j.metabol.2022.155270_bb0135","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"10.1016\/j.metabol.2022.155270_bb0140","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/ije\/dyt179","article-title":"Calculating statistical power in Mendelian randomization studies","volume":"42","author":"Brion","year":"2013","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.metabol.2022.155270_bb0145","article-title":"Machine learning enables new insights into genetic contributions to liver fat accumulation","volume":"1","author":"Haas","year":"2021","journal-title":"Cell Genom"},{"key":"10.1016\/j.metabol.2022.155270_bb0150","doi-asserted-by":"crossref","first-page":"113","DOI":"10.12688\/wellcomeopenres.15334.1","article-title":"Using the MR-base platform to investigate risk factors and drug targets for thousands of phenotypes","volume":"4","author":"Walker","year":"2019","journal-title":"Wellcome Open Res"},{"key":"10.1016\/j.metabol.2022.155270_bb0155","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1136\/gutjnl-2020-322572","article-title":"Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals","volume":"70","author":"Mantovani","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.metabol.2022.155270_bb0160","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41575-021-00448-y","article-title":"The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments","volume":"18","author":"Targher","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.metabol.2022.155270_bb0165","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1002\/hep.31095","article-title":"Ceramides: a cause of insulin resistance in nonalcoholic fatty liver disease in both murine models and humans","volume":"71","author":"Yki-J\u00e4rvinen","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2022.155270_bb0170","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nature13478","article-title":"The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes","volume":"510","author":"Perry","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2022.155270_bb0175","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.cmet.2019.11.018","article-title":"Hepatic lipoprotein export and remission of human type 2 diabetes after weight loss","volume":"31","author":"Al-Mrabeh","year":"2020","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2022.155270_bb0180","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.2337\/dc20-0329","article-title":"Role of patatin-like phospholipase domain-containing 3 gene for hepatic lipid content and insulin resistance in diabetes","volume":"43","author":"Zaharia","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2022.155270_bb0185","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jhep.2014.10.010","article-title":"Circulating triacylglycerol signatures and insulin sensitivity in NAFLD associated with the E167K variant in TM6SF2","volume":"62","author":"Zhou","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2022.155270_bb0190","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S2213-8587(18)30315-2","article-title":"Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management","volume":"7","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.metabol.2022.155270_bb0195","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.atherosclerosis.2019.01.029","article-title":"Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps","volume":"282","author":"Santos","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2022.155270_bb0200","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-004973","article-title":"Fatty liver predicts the risk for cardiovascular events in middle-aged population: a population-based cohort study","volume":"4","author":"Pisto","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.metabol.2022.155270_bb0205","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S2213-8587(16)00082-6","article-title":"Phenotypes of prediabetes and stratification of cardiometabolic risk","volume":"4","author":"Stefan","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.metabol.2022.155270_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101092","article-title":"Dysregulated lipid metabolism links NAFLD to cardiovascular disease","volume":"42","author":"Deprince","year":"2020","journal-title":"Mol Metab"},{"key":"10.1016\/j.metabol.2022.155270_bb0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/j.2040-4603.2018.tb00008.x","article-title":"Triglyceride metabolism in the liver","volume":"8","author":"Alves-Bezerra","year":"2017","journal-title":"Compr Physiol"},{"key":"10.1016\/j.metabol.2022.155270_bb0220","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/hep.30908","article-title":"Lean NAFLD: a distinct entity shaped by differential metabolic adaptation","volume":"71","author":"Chen","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2022.155270_bb0225","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJMoa1806747","article-title":"Mendelian randomization study of ACLY and cardiovascular disease","volume":"380","author":"Ference","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2022.155270_bb0230","article-title":"Relationship between non-alcoholic fatty liver disease and coronary artery disease: a Mendelian randomization study","author":"Ren","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2022.155270_bb0235","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S2468-1253(21)00308-3","article-title":"Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis","volume":"6","author":"Mantovani","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.metabol.2022.155270_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2022.155220","article-title":"Nonalcoholic fatty liver disease and cardiovascular diseases: a Mendelian randomization study","volume":"133","author":"Peng","year":"2022","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2022.155270_bb0245","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jacc.2021.11.007","article-title":"Risk of heart failure in patients with nonalcoholic fatty liver disease: JACC review topic of the week","volume":"79","author":"Mantovani","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.metabol.2022.155270_bb0250","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1038\/ng.3977","article-title":"Exome-wide association study of plasma lipids in >300,000 individuals","volume":"49","author":"Liu","year":"2017","journal-title":"Nat Genet"},{"key":"10.1016\/j.metabol.2022.155270_bb0255","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1053\/j.gastro.2016.12.020","article-title":"PNPLA3, TM6SF2, and MBOAT7 genotypes and coronary artery disease","volume":"152","author":"Simons","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.metabol.2022.155270_bb0260","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0140-6736(12)60987-8","article-title":"Diabetes and hypertension: the bad companions","volume":"380","author":"Ferrannini","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2022.155270_bb0265","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1097\/HJH.0b013e32833c211b","article-title":"The association between fatty liver disease and blood pressure in a population-based prospective longitudinal study","volume":"28","author":"Lau","year":"2010","journal-title":"J Hypertens"},{"key":"10.1016\/j.metabol.2022.155270_bb0270","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1111\/jgh.12643","article-title":"Clinical association between non-alcoholic fatty liver disease and the development of hypertension","volume":"29","author":"Ryoo","year":"2014","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.metabol.2022.155270_bb0275","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1161\/HYPERTENSIONAHA.119.13419","article-title":"Nonalcoholic fatty liver disease: an emerging driver of hypertension","volume":"75","author":"Zhao","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.metabol.2022.155270_bb0280","doi-asserted-by":"crossref","DOI":"10.3390\/nu11071602","article-title":"Western diet-induced metabolic alterations affect circulating markers of liver function before the development of steatosis","volume":"11","author":"Gabbia","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.metabol.2022.155270_bb0285","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/nm1785","article-title":"Hepatic insulin resistance directly promotes formation of cholesterol gallstones","volume":"14","author":"Biddinger","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.metabol.2022.155270_bb0290","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1136\/gutjnl-2021-324191","article-title":"Non-alcoholic fatty liver disease and increased risk of incident extrahepatic cancers: a meta-analysis of observational cohort studies","volume":"71","author":"Mantovani","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.metabol.2022.155270_bb0295","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1111\/liv.15244","article-title":"Association between non-alcoholic fatty liver disease and the risk of dementia: a nationwide cohort study","volume":"42","author":"Kim","year":"2022","journal-title":"Liver Int"},{"key":"10.1016\/j.metabol.2022.155270_bb0300","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000200770","article-title":"Association of nonalcoholic fatty liver disease and fibrosis with incident dementia and cognition: the Rotterdam study","author":"Xiao","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.metabol.2022.155270_bb0305","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1007\/s11605-019-04417-4","article-title":"A systematic review of intra-pancreatic fat deposition and pancreatic carcinogenesis","volume":"24","author":"Sreedhar","year":"2020","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.metabol.2022.155270_bb0310","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/acn3.51516","article-title":"Lipid levels and the risk of dementia: a dose-response meta-analysis of prospective cohort studies","volume":"9","author":"Zhu","year":"2022","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.metabol.2022.155270_bb0315","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","article-title":"Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders","volume":"14","author":"Sweeney","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.metabol.2022.155270_bb0320","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.brainresbull.2018.11.012","article-title":"Lipid metabolism in Alzheimer's disease","volume":"144","author":"Zhu","year":"2019","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.metabol.2022.155270_bb0325","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S1474-4422(20)30412-9","article-title":"APOE and Alzheimer's disease: advances in genetics, pathophysiology, and therapeutic approaches","volume":"20","author":"Serrano-Pozo","year":"2021","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.metabol.2022.155270_bb0330","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1053\/j.gastro.2020.12.023","article-title":"Exome-wide association study on alanine aminotransferase identifies sequence variants in the GPAM and APOE associated with fatty liver disease","volume":"160","author":"Jamialahmadi","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.metabol.2022.155270_bb0335","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1001\/jama.298.11.1300","article-title":"Association of apolipoprotein E genotypes with lipid levels and coronary risk","volume":"298","author":"Bennet","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.metabol.2022.155270_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2022.155246","article-title":"Time to transition from a negative nomenclature describing what NAFLD is not, to a novel, pathophysiology-based, umbrella classification of fatty liver disease (FLD)","volume":"134","author":"Valenzuela-Vallejo","year":"2022","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2022.155270_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103584","article-title":"What the new definition of metabolic dysfunction-associated fatty liver disease (MAFLD) left behind: genetically acquired fatty liver disease (GAFLD)","volume":"72","author":"Bril","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.metabol.2022.155270_bb0350","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1093\/ije\/dyy060","article-title":"Exploring the association of genetic factors with participation in the Avon Longitudinal Study of Parents and Children","volume":"47","author":"Taylor","year":"2018","journal-title":"Int J Epidemiol"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049522001482?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049522001482?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:30:30Z","timestamp":1758429030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049522001482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":70,"alternative-id":["S0026049522001482"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2022.155270","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dissecting causal relationships between nonalcoholic fatty liver disease proxied by chronically elevated alanine transaminase levels and 34 extrahepatic diseases","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2022.155270","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"155270"}}